Indications -- Psoriasis/Chronic Inflammation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (308)	12/18/2002 4:55:48 PM
From: fred hayes	Read Replies (1) of 631

>>[ anti-alpha-1/BGEN sells ELN down river ]<< Got my attention, but I'm not sure I digested this one. I took the BGEN release to mean that they were onto a new lead for IBD that was different than but similar to Antegren. I didn't think of it as selling ELN out, nor was I sure the new lead sounded superior to Antegren. BGEN and ELN are full partners in Antegren, not only for Crohn's but also MS. Plus, the new lead sounds like it would be many years away from a drug. Why the "sells ELN down river.."? fred

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next